JPMORGAN CHASE & CO - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 31 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$72,598
-18.9%
43,734
-2.3%
0.00%
Q2 2023$89,52044,760
+11231.6%
0.00%
Q2 2022$0
-100.0%
395
-65.0%
0.00%
Q1 2022$1,000
-87.5%
1,127
-80.7%
0.00%
Q3 2021$8,000
+33.3%
5,847
+352.2%
0.00%
Q1 2021$6,000
-25.0%
1,293
-38.4%
0.00%
Q4 2020$8,0000.0%2,1000.0%0.00%
Q3 2020$8,0002,100
+2000.0%
0.00%
Q2 2020$01000.0%0.00%
Q4 2019$01000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Burrage Capital Management LLC 2,125,585$9,480,0007.68%
DAFNA Capital Management LLC 1,204,825$5,374,0001.28%
Psagot Value Holdings Ltd. 3,095,741$13,807,0000.31%
Ground Swell Capital, LLC 14,684$65,0000.21%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 445,171$1,985,000,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,591$1,350,0000.02%
Phoenix Holdings Ltd. 244,113$1,089,0000.02%
Virtu Financial LLC 27,744$124,0000.01%
D.A. DAVIDSON & CO. 130,700$583,0000.01%
Schonfeld Strategic Advisors LLC 89,278$399,0000.01%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders